FLUIMUCIL GRANULES 600MG/SACHET [SIN15144P]

Product Info

FLUIMUCIL GRANULES 600MG/SACHET

[SIN15144P]

INDICATIONS
Fluimucil® A Effervescent Tablets 600mg and Fluimucil® Granules 600mg are indicated as an adjuvant treatment in certain clinical condition characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as:

• Chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis);

• Acute bronchopulmonary diseases (asthma with bronchial mucus plugging, bronchitis, bronchopneumonia, tracheobronchitis, bronchiolitis, pulmonary complications of cystic fibrosis, pulmonary complications associated with surgery).

POSOLOGY
Adults and children above 6 years

• 1 tablet of Fluimucil® A Effervescent Tablet 600 mg a day.

• 1 sachet of Fluimucil® Granules 600mg a day.

The duration of treatment should be 5 to 10 days in the acute treatment, whereas it may be continued in the chronic states for several months, according to the advice of the physician.

CONTRAINDICATIONS

• Known hypersensitivity to acetylcysteine or to any of the excipients (please see below the section Warning and Precautions – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

• Children under 2 years of age.

• Fluimucil® A Effervescent Tablets 600mg and Fluimucil® Granules 600mg contain aspartame, thus it is contraindicated in patients suffering from phenylketonuria.